Pancreatic Enzymes and Cancer
Dr. Nicholas Gonzalez's specially formulated pancreatic enzymes represent the backbone of The Gonzalez Protocol®. Conventional physiologists for over a hundred years have taught that pancreatic enzymes have only one purpose, to facilitate digestion of food. However, the English researcher Dr. John Beard first suggested in 1902 that pancreatic protein-digesting enzymes also represent our body's main defense against cancer, and could be useful as a cancer treatment.
Both animal and human studies, in Beard's time and more recently, have confirmed an anti-cancer action for pancreatic enzymes. This 2022 peer-reviewed Integrative Cancer Therapies scientific journal article "Pancreatic Proteolytic Enzymes and Cancer: New Support for an Old Theory" reviews the history of the clinical use of pancreatic proteolytic enzymes in cancer treatment, and recent research on protease activated receptors and their role in cancer.
- For further information about our use of pancreatic enzymes, we suggest the comprehensive article "The History of the Enzyme Treatment of Cancer" published in the peer-reviewed journal Alternative Therapies in Health and Medicine.
- For a shorter article with much of the same information, read this article.
- For an in-depth evaluation of enzyme therapy, including contemporary support for Dr. Beard's work, please consult the book The Trophoblast and the Origins of Cancer available through New Spring Press.
